Article2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D. Solomon, Adel R. Rizkala, Martin Lefkowitz, Victor Shi, Jianjian Gong, Nagesh S. Anavekar, Stefan D. Anker, Juan Luis Arango, J. Arenas, Dan Atar, T. Ben-Gal, S. А. Boytsov, Chen-Huan Chen, Vijay Chopra, John G.F. Cleland, Josep Comín‐Colet, H DUENGEN, Luis Eduardo Echeverría, Gerasimos Filippatos, Andreas J. Flammer, Michel Galinier, Armando Godoy, Eva Gonçalvesová, Stefan Janssens,
Article2021
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser, Sylvère Durand, Rui Adão, Francisco Vasques‐Nóvoa, Johanna K. Freundt, Julia Voglhuber, María Rosaria Pricolo, Michael Kasa, Clara Türk, Fanny Aprahamian, Elías Herrero‐Galán, Sebastian J. Hofer, Tobias Pendl, Lavinia Rech, Julia Kargl, Nathaly Anto-Michel, Senka Ljubojević-Holzer, Julia Schipke, Christina Brandenberger, Martina Auer, Renate Schreiber, Chintan N. Koyani, ,
Discussion(0)
No comments yet. Be the first to comment.